← FDA DRUG APPROVALS

FDA ANDA · ANDA087202

PHENTERMINE HYDROCHLORIDE

Sponsor: VITARINE

APPLICATION
ANDA087202
TYPE
ANDA
LATEST ACTION
1985-01-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued
PHENTERMINE HYDROCHLORIDE 30MG · CAPSULE · ORAL

Approval history

1985-01-30Manufacturing (CMC) · Supplement 8AP
1983-11-10Manufacturing (CMC) · Supplement 6AP
1983-09-02Manufacturing (CMC) · Supplement 5AP
1983-09-02Manufacturing (CMC) · Supplement 4AP
1982-02-03Manufacturing (CMC) · Supplement 1AP
1982-02-03Manufacturing (CMC) · Supplement 2AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →